George Harston

George Harston is a Consultant Physician in Stroke and Internal Medicine at Oxford University Hospitals and Chief Medical & Innovation Officer at Brainomix. He is a clinical academic and MedTech industry leader with a track record in developing, validating, and deploying AI imaging software across stroke, interstitial lung disease (ILD), and oncology. He led the largest-ever prospective evaluation of stroke imaging AI through the NHS AI in Health and Care Award. He has driven widespread clinical adoption of AI imaging technologies and informed national stroke guidelines.

At Brainomix, he leads translational medicine, product management, medical affairs, and the Life Sciences business unit. He also established and oversees a US-based expert imaging core lab supporting academic and industry clinical trials.

Dr Harston maintains an active research and teaching portfolio, supervises doctoral and postgraduate trainees. He serves on the Editorial Board of Neuroimage: Stroke and the Board of Directors (as Chair) of the Open Source Imaging Consortium for ILD. His research focusses on acute neuroimaging in stroke and interstitial lung diseases, with a particular interest in CT and MRI methodologies, including non-contrast metabolic and perfusion imaging. 

Dr Harston was awarded my medical degree from the University of Cambridge in 2006. He completed his DPhil in Clinical Medicine in 2015, before taking up a Clinical Lecturer position later that year. He was appointed as a Consultant Physician in Acute General Medicine, Geratology and Stroke Medicine at Oxford University Hospitals NHS Foundation Trust in 2018, and as Chief Medical and Innovation Officer at Brainomix, a spin-out company from the University of Oxford.